Internal Medicine, Pulmonary Disease · New Iberia, LA
NPI
1588602056
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2309 E Main St, Suite 202
New Iberia, LA, 70560
Phone (337) 364-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$179K
3,034 services
Medicare patients, 2024
1,082
Average age 73
Drug cost, 2024
$2.4M
5,098 prescriptions
Company payments, 2025
$1,270
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Moses M Kitakule was code 99213 (office e&m - established), 1,309 times for 904 patients. In total Moses M Kitakule billed 3,034 services in 38 codes, and Medicare paid $179K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,309 | 904 | $62.10 | $81K |
| 94010 Pulmonary Function Testing | Office | 245 | 228 | $17.84 | $4,372 |
| 94060 Pulmonary Function Testing | Office | 194 | 180 | $25.40 | $4,928 |
| 99232 Hospital E&M - Subsequent | Facility | 177 | 67 | $58.81 | $10K |
| 99291 Critical Care E&M | Facility | 130 | 49 | $159.72 | $21K |
| 94729 Pulmonary Function Testing | Office | 129 | 128 | $37.28 | $4,809 |
| 94727 Pulmonary Function Testing | Office | 129 | 128 | $29.02 | $3,744 |
| 99204 Office E&M - New | Office | 96 | 96 | $114.68 | $11K |
| 99223 Hospital E&M - Initial | Facility | 57 | 53 | $129.10 | $7,359 |
| 99214 Office E&M - Established | Office | 51 | 49 | $90.64 | $4,622 |
| 99233 Hospital E&M - Subsequent | Facility | 47 | 29 | $88.64 | $4,166 |
| 99203 Office E&M - New | Office | 47 | 47 | $65.57 | $3,082 |
| 99211 Office E&M - Established | Office | 46 | 43 | $15.83 | $728 |
| 95800 Sleep Study | Office | 45 | 45 | $85.67 | $3,855 |
| 94664 E&M - Miscellaneous | Office | 42 | 41 | $12.15 | $510 |
By year: 2022 $278K for 4,333 services; 2023 $236K for 3,641 services; 2024 $179K for 3,034 services.
Medicare prescription drug claims, 2024
In 2024, the drug Moses M Kitakule prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 978 prescriptions and refills. In total Moses M Kitakule wrote 5,098 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 978 | 1,282 | 187 | $800K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 945 | 1,113 | 271 | $28K |
| Breo Ellipta Fluticasone/Vilanterol | 688 | 838 | 146 | $327K |
| Symbicort Budesonide/Formoterol Fumarate | 378 | 494 | 104 | $112K |
| Breyna Budesonide/Formoterol Fumarate | 168 | 207 | 42 | $35K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 167 | 189 | 38 | $117K |
| Spiriva Handihaler Tiotropium Bromide | 158 | 194 | 36 | $98K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 146 | 209 | 37 | $23K |
| Fluticasone Propionate Generic | 122 | 201 | 45 | $1,158 |
| Incruse Ellipta Umeclidinium Bromide | 105 | 121 | 21 | $41K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 105 | 114 | 32 | $20K |
| Ventolin Hfa Albuterol Sulfate | 103 | 107 | 29 | $5,734 |
| Montelukast Sodium Generic | 98 | 194 | 25 | $839 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 67 | 74 | 13 | $33K |
| Spiriva Respimat Tiotropium Bromide | 66 | 68 | 14 | $35K |
Brand drugs: 3,652 claims; generic drugs: 1,446 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Moses M Kitakule $1,270 ($1,270 in general payments such as food, travel and fees) from 10 companies. The largest payer was GlaxoSmithKline, LLC. with $579.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 28 | $579 |
| Genzyme Corporation SNY | 10 | $252 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $165 |
| Verona Pharma, Inc. VRNA | 3 | $58.71 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $51.26 |
| Inspire Medical Systems, Inc. INSP | 1 | $45.45 |
| Insmed, Inc. INSM | 2 | $39.27 |
| Amgen Inc. AMGN | 1 | $34 |
| Merck Sharp & Dohme LLC MRK | 1 | $26.56 |
| Liquidia Technologies, Inc. | 1 | $18.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.